|
|
| Line 1,356: |
Line 1,356: |
| *2012-2013 [https://www.srnt.org/page/Presidents President, Society for Research on Nicotine and Tobacco] | | *2012-2013 [https://www.srnt.org/page/Presidents President, Society for Research on Nicotine and Tobacco] |
| *[https://ajph.aphapublications.org/doi/full/10.2105/AJPH.2021.306416 Balancing Consideration of the Risks and Benefits of E-Cigarettes] | | *[https://ajph.aphapublications.org/doi/full/10.2105/AJPH.2021.306416 Balancing Consideration of the Risks and Benefits of E-Cigarettes] |
| <br>
| |
|
| |
| ===Abigail S. Friedman, Ph.D.===
| |
| *[https://twitter.com/AFriedmanPhD Follow on Twitter]
| |
| *Source: [https://clivebates.com/documents/ExpertCommentsOnWHOMay2021.pdf Comments on vaping and tobacco harm reduction from expert stakeholders]
| |
| **A myriad of studies link e-cigarette price increases and access-restrictions to greater smoking rates. Findings from biochemical analyses suggest that such regulations are likely to be harmful on net: vaping nicotine appears to produce substantially lower levels of key toxicants than smoking cigarettes; and, adverse respiratory and cardiovascular outcomes as well as biomarkers for major carcinogens generally fall when smokers switch to nicotine e-cigarettes. Thus, for smokers who do not want to quit tobacco or who want to quit but have been unsuccessful in their cessation attempts, substituting towards electronic nicotine delivery systems offers a means to reduce their risk of tobacco-related illness. The public health community and World Health Organization have a moral obligation to clearly communicate these facts to smokers and their families, and to advocate for policies that reflect tobacco products’ relative risks.”
| |
| **Abigail S. Friedman, Ph.D. - [https://ysph.yale.edu/profile/abigail_friedman/ Bio and Photo]
| |
| **Assistant Professor,
| |
| **Department of Health Policy and Management
| |
| **Yale School of Public Health
| |
| <br> | | <br> |
|
| |
|
